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BACKGROUND: The Glu27Glu genotype in the beta-2-adrenergic receptor (ADRB2) is associated with fat mass, body mass
index and obesity in females. In our population, we previously found an association of higher body mass index (BMI) among
women who reported more physical activity and carried the Glu27 allele as compared to non carriers with the same level of
activity.
OBJECTIVE: To examine the lipid metabolism differences, both at rest and during submaximal exercise in ADRB2 Glu27Glu vs
Gln27Gln obese women.
SUBJECTS: Eight obese women with the Glu27Glu genotype (age, 435 y; body mass index (BMI), 31.70.9 kg=m2;
percentage fat mass, 42.0 1.3; WHR, 0.830.02; and VO2max, 21.60.9 ml=kg=min) were compared with seven obese
women with the Gln27Gln genotype (age, 43 5 y; BMI, 33.9 1.3 kg=m2; percentage fat mass, 41.61.2; WHR, 0.830.02;
and VO2max, 20.60.8 ml=kg=min).
MEASUREMENTS: The ADRB2 polymorphism was identified by PCR-RFLP. Respiratory quotient was determined by indirect
calorimetry at baseline, during 1 h of walking on a treadmill and 1 h after the exercise. Plasma triglycerides, glycerol, FFA,
hydroxybutyrate, glucose and lactate were assayed by spectrophotometric methods. Insulin, leptin and progesterone were
measured by radioimmunoassay. Adrenaline and noradrenaline were quantified by high performance liquid chromatography.
RESULTS: The ADRB2 Glu27Glu subjects had lower plasma glycerol (P¼0.047) and lower hydroxybutyrate (P¼ 0.001)
throughout the study than the Gln27Gln group. Plasma triglycerides (P¼0.001), lactate (P<0.05) and serum insulin
(P< 0.05) remained higher in the Glu27Glu group vs the Gln27Gln group. The respiratory quotient (RQ) was higher in the
Glu27Glu obese women along the study (P¼0.046), and fat oxidation was significantly lower in this group during the recovery
(P¼ 0.048). The other variables did not differ statistically between groups.
CONCLUSION: These data suggest that both lipolysis and fat oxidation promoted by an acute submaximal exercise intervention
could be blunted in the polymorphic ADRB2 Glu27Glu group of our female obese population.
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Introduction
The b2-adrenergic receptor (ADRB2) is a major lipolytic
receptor in human fat cells.1 Although adipose tissue con-
tains b1-, b2- and b3-adrenoceptors, obesity-induced catecho-
lamine resistance appears primarily because of defects in
b2-stimulation.2,3 Furthermore, it has been suggested that
ADRB2 is responsible for the impaired effects in thermo-
genesis, lipid oxidation and lipolysis in the obese in vivo.4
Several polymorphisms have been described5 both in the
coding region of the ADRB2 gene (Arg16Gly, Gln27Gln,
Thr164Ile) and in the 50 leader cistron (Cys19Arg), that
result in significantly changed functions of this receptor.6 – 8
Indeed, polymorphisms in the coding region showed an
ADRB2 functional impairment in recombinant cells.6,9
Available data raise arguments for10 – 19 and against20 – 22
the association of obesity with the Gln27Glu polymorphism.
In a Swedish population,11 Glu27Glu women have an
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average fat mass excess of 20 kg and 50% larger fat cells
than controls. In this study, the Gln27Glu polymorphism
was markedly associated with obesity with a relative risk for
obesity of 7 and an odds ratio of 10. Interestingly,
Meirhaeghe et al have reported that polymorphisms in the
ADRB2 gene influence the effects of physical activity in
the determination of the level of FFA23 and of the body
mass index (BMI).16 Thus, Gln27Glu polymorphism has
been strongly associated with obesity in patients reporting
no physical activity, and physical activity might counter-
balance the effect of a genetic predisposition to increase
body weight, body fat and obesity.16 Indeed, Glu27Glu
Caucasian postmenopausal women had higher weight, BMI
and fat mass with a lower maximal O2 consumption than the
other ADRB2 genotypes.24 In our population, we previously
found an association of higher BMI among women who
reported more physical activity and carried the Glu27 allele
as compared with non-carriers.25 This suggests that women
bearing the Glu27 allele do not benefit equally from exercise
and appear to be more resistant to weight loss when report-
ing high levels of physical activity.
Walking is often included in studies of exercise in relation
to disease,26 but has seldom been specifically tested in rela-
tion to obesity and gene variants.23,27 During low-intensity
exercise (25 – 40% VO2max), such as walking, there is an
increased release of FFA into the circulation as a product of
triacylglycerol hydrolysis in the adipose tissue.28 This lipo-
lysis is a key step in the metabolic process leading to the
decrease of fat mass and is mainly regulated by catechola-
mines and insulin.29
Therefore, the present study was designed to examine the
lipid metabolism differences, both at rest and during sub-
maximal exercise in ADRB2 Glu27Glu vs Gln27Gln obese
women.
Methods
Subjects
In our study, eight Glu27Glu obese women were compared
with seven Gln27Gln obese women, matched by age, BMI,
percentage of body fat mass, waist-to-hip ratio and peak
oxygen consumption (Table 1). These groups were selected
after having genotyped 129 obese subjects (BMI>30 kg=m2,
age 20 – 60) from the Hospital of Navarra, Spain. Diabetes
mellitus, hypothyroidism, hepatic or renal dysfunction,
hypertension (systolic pressure over 160 mmHg and=or
diastolic pressure over 90 mmHg, measured on two different
occasions), cardiopathies, asthma, bronchitis, EPOC, bone or
joint disturbances, alcohol or drug addiction and smoking
were considered exclusion criteria. The study was approved
by the ethical committee of Navarra and informed consent
was signed by all volunteers before the study.
Analysis of PCR-RFLP
Genomic DNA was extracted from leukocytes in samples of
whole blood by proteinase K digestion followed by phenol=
chloroform extraction. PCR amplification was performed on
a Perkin Elmer, Gene Amp PCR system 2400, Applied
Biosystems, Foster City, CA, USA.
The 30 ml reaction volume contained 150 – 250 ng DNA,
0.2 mM of each deoxynunucleoside triphosphate, 1buffer
(10 mM Tris – HCl, 1.5 mM MgCl2, 5 mM KCl, pH 8.3),
20 pmol of each primer, and 1 U of Biotaq DNA Polymerase.
The following primers were used to amplify a 310 base pair
(bp) fragment: 50-CCGCCGTGGGTCCGCC-30 (forward) and
50-CCATGACCAGATCAGCAC-30 (reverse). The PCR program
was a modification of Large et al:11 each step of the cycle
lasted 30 s and the annealing temperature was 64C. The 310
bp PCR product was digested with 5 units of ItaI or with its
Table 1 Anthropometric, food intake, fitness and basal characteristics of subjects participating in the
submaximal exercise study
Characteristic Glu27Glu (n¼ 8) Gln27Gln (n¼7) Statistical analysis P
Age (y) 43 (5) 43 (5) T 0.901
Height (m) 1.59 (0.02) 1.59 (0.03) T 0.948
BMI (kg=m
2
) 31.7 (0.9) 33.9 (1.3) T 0.175
Percentage fat mass 42.0 (1.3) 41.6 (1.2) T 0.842
Fat mass (kg) 33.6 (1.8) 34.4 (1.3) T 0.772
Waist (cm) 94.19 (2.9) 97.5 (3.3) T 0.467
WHR 0.83 (0.02) 0.83 (0.02) U 0.755
Caloric intake (kJ) 6835.7 (502.3) 7388.3 (569.3) T 0.478
Percentage fat intake 34 (4) 32 (2) T 0.724
Percentage CHO 49 (5) 52 (2) T 0.676
VO2max (ml=kg=min) 21.6 (0.9) 20.6 (0.8) T 0.613
Percentage VO2max 32.3 (1.1) 35.6 (1.4) T 0.121
Maximal HR (beat=min) 170 (5) 168 (3) T 0.750
Maximal RQ 1.34 (0.05) 1.31 (0.02) T 0.612
Progesterone (ng=ml) 0.39 (0.07) 0.44 (0.08) T 0.656
Values are means (s.e.m.). BMI, body mass index; WHR, waist to hip ratio; CHO, carbohydrate; VO2max, peak
oxygen consumption; percentage VO2max, percentage of peak oxygen consumption developed in the
submaximal exercise study. T, Student’s t-test. U, Mann – Whitney’s U-test.
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isoschizomer Fnu4HI overnight. The obtained fragments
sized 84 and 226 bp for the Glu27 allele and 84, 55 and
171 bp for the Gln27 allele. They were observed on an
ethydium bromide stained 1.35% agarose gel, under UV
illumination.
Peak oxygen consumption test
Subjects arrived at 8.00 am to the hospital unit and weight,
height, waist circumference and hip circumference were
measured to calculate BMI and waist-to-hip ratio (WHR).
Body fat (BF) was measured by bioimpedance (TANITA
TBF-300, Bio Logica, Japan). All participants were studied
with a multistage exercise treadmill test according to the
Bruce protocol30 using a breath-by-breath MMC Horizon
System 4400 tc, SensorMedics, Anaheim, CA, USA. Exhaus-
tion was considered when at least three of the four following
criteria were fulfilled: (a) heart rate (HR) over 85% of max-
imal HR calculated by the age predicted formula; (b) respira-
tory exchange ratio (RER) over 1.2; (c) a plateau in O2
consumption (VO2), despite an increase in workload, and
(d) an inability of the subject to continue despite urging by
the testing staff. Data from the VO2max test were used to
screen for evidence of cardiovascular disease and therefore
exclude them from the study, given that obese patients have
an increased risk of developing such diseases.31,32
Submaximal test
Approximately 20 days after the VO2max test, volunteers
arrived at 8.00 am at the hospital unit by car or public
transport. They were requested to avoid strenuous physical
exercise 36 – 48 h before the study. Eumenorrheic women
came during the follicular phase of their menstrual cycle
(days 6 – 10 after menstruation began) and serum progester-
one was drawn to ensure that they were in the follicular
state.33 The last meal before the study consisted of 100 g of
pasta with 40 g of olive oil-tomato sauce and 125 g
of yoghurt. Urine was collected in the basal state after an
overnight fast (12 h) and at the end of the study. The
anthropometrical measurements were repeated to ensure
that weight had not changed since the VO2max test. Volun-
teers completed a 24 h food intake recall of the day before the
testing session. An intravenous catheter was inserted in the
right arm and all subjects rested undisturbed during 40 min
before the first sample of blood was extracted and every
30 min a new blood sample was drawn until the end of the
study. Immediately following the first blood sample extrac-
tion, all participants walked on the mentioned treadmill for
60 min at a constant speed that elicited 30 – 35% of their
individual VO2max, obtained in the previous intervention.
The treadmill speed or walking pace (km=h) was calculated
taking into account McArdle’s tables, which relate energy
expenditure (kJ=min), speed (km=h) and body mass (kg).34
Samples of breath gases were collected 30 min before,
during, and 60 min after the exercise. Basal urine urea was
used to estimate nitrogen excretion and thus to calculate
basal protein oxidation. Postexercise urine urea was used to
estimate protein oxidation both during the exercise and the
postexercise period (urea (mg=dl)0.0055¼urinary nitrogen
(g=l)). After correction for protein oxidation, carbohydrate
and lipid oxidation rates were calculated from O2 consump-
tion and CO2 production as described by Ferrannini.
35 For
carbohydrate oxidation, the glycogen formula was employed
as roughly three-quarters of plasma glucose turnover is
derived from liver glycogenolysis after an overnight fast.35,36
The 24 h recall food intake was analyzed with a computerized
program by a trained nutritionist on a computerized program
(Medisystem, SanoCare, Madrid, Spain).37
Analytical methods
Plasma glucose, triglycerides, glycerol, FFA, D-3-hydroxy-
butyrate and urine urea were determined with a Cobas Mira S
apparatus, by spectrophotometric methods. Plasma lactate
was placed in a fluoride EDTA tube and was determined in
the same apparatus. Serum progesterone and insulin (Coat-
A-Count, Progesterone and Insulin, respectively, DPC, Los
Angeles, CA, USA), as well as leptin (Human Leptin IRMA,
DSL, Webster, TX, USA) were measured by radioimmunoassay
(DPC Gambyt, Los Angeles, CA, USA). Plasma noradrenaline
and adrenaline levels were determined by HPLC, according
to the method described by Boomsma et al.38
Data analysis
All data are presented as the mean (s.e.m.). Variables listed in
Table 1 and fat oxidation were analyzed by either unpaired
Student’s t-test or Mann – Whitney’s U-test, as appropriate,
depending on normality test results. A chi-square test was
used to analyze the allelic distribution. Time – group inter-
action, time-effect and differences between groups were
analyzed with a repeated measures factorial ANOVA (RMFA)
in both biochemical and RQ values. When ANOVA for time
was significant, post-hoc Tukey B test was performed. When
ANOVA for group was significant, unpaired Student’s t-test
was performed.4 The SPSS 7.5 version for WINDOWS was
used for the statistical analysis.
Results
Population genotype
Allelic frequency of the Glu27 allele was 0.43, and did not
differ from other genotyped obese Caucasian populations.
This obese population was in Hardy – Weinberg equilibrium
(w2¼0.58212, d.f.¼1, P¼0.58). The frequencies of geno-
types were 0.325 in Gln27Gln, 0.185 in Glu27Glu and 0.49
in Gln27Glu. The selected Glu27Glu obese women (n¼8)
were compared with other Gln27Gln obese female subjects
(n¼7), matched by age, BMI, fat mass, WHR and VO2max.
The two groups did not differ statistically (Table 1) in any of
the former criteria (P>0.10).
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Metabolic measurements
Plasma triglycerides (TG) remained higher (ANOVA for
group, P<0.001) in the Glu27Glu group along the study.
Recovery data were significantly lower (Tukey B, P<0.05)
than exercise values (Figure 1A).
The Glu27Glu group had significantly lower values of
plasma glycerol (ANOVA for group, P¼0.047) than the
Gln27Gln group along the whole study. Exercise values
were significantly higher (Tukey B, P<0.05) than basal and
postexercise values (Figure 1B).
Plasma FFA increased (Tukey B, P<0.05) with the onset of
exercise, and decreased (Tukey B, P<0.05) after the exercise
(Figure 1C). No differences between groups were detected
(ANOVA for group, P>0.05).
The Glu27Glu group had significantly lower values of
plasma hydroxybutyrate (ANOVA for group, P<0.001) than
the Gln27Gln group along the whole study. Recovery time
values were significantly higher (Tukey B, P<0.05) than
basal and exercise values (Figure 1D).
Table 2 shows values of plasma glucose, lactate, insulin,
leptin and catecholamines throughout the study. Plasma
lactate decreased (Tukey B, P<0.05) with the onset of exer-
cise, whereas glucose recovery values were higher (Tukey B,
P<0.05) than exercise values. Insulin decreased with the
onset of exercise (Tukey B, P<0.05) and returned to basal
values during the recovery (Tukey B, P<0.05), whereas
plasma leptin decreased significantly after the exercise
(Tukey B, P<0.05). Noradrenaline was significantly higher
during exercise and decreased to basal values during the
recovery (Tukey B, P<0.05). Although no statistical differ-
ences were found between groups in plasma catecholamines
throughout the study, noradrenaline tended to be higher in
the Glu27Glu group (ANOVA for group, P¼0.090).
Respiratory quotient was significantly higher in the
Glu27Glu group than in the Gln27Gln group during
the whole study (ANOVA for group, P¼0.046; Figure 2A).
No group – time interaction was found in any of the
measurements along the whole study.
Neither carbohydrate nor protein oxidation differed
between groups (Student’s unpaired t-test, P>0.05). Fat
oxidation was not different between groups both at basal
and exercise period, but was significantly lower (Student’s
unpaired t-test, P¼0.048) in the Glu27Glu group than in the
Gln27Gln group during the recovery (Figure 2B).
Discussion
The present data indicate that the ADRB2 Glu27Glu obese
women group is different from its Gln27Gln matched
group concerning lipid metabolism. Hence, the Glu27Glu
group had a lower lipolysis along the study, as assessed by
plasma glycerol. In addition, the RQ was significantly higher
in the variant Glu27Glu group during the whole study, and
its fat oxidation was significantly lower during the recovery.
This was supported with the finding that plasma hydroxy-
butyrate remained lower all along the intervention in the
Glu27Glu group.
Recently, it has been shown that Caucasian postmeno-
pausal women bearing the Glu27Glu genotype have higher
body weight, BMI and fat mass as compared to the other
ADRB2 genotypes.24 As the lower VO2max reached by women
in such study may be due to their excess of fat mass, our
groups were matched for these two criteria. In a Spanish
Figure 1 Plasma triglycerides (A), glycerol (B), FFA (C), and hydroxy-
butyrate (D) in Gln27Gln subjects and Glu27Glu subjects along the
study. Values are the mean (s.e.m.). ###P<0.001 (by RMFA for time);
*P<0.05 (by unpaired Student’s t-test). BL, baseline.
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population, we previously found that obese women who
reported to be more physically active in their leisure time
and were carriers of the Glu27 allele had higher BMI as
compared to non carriers performing the same level of
exercise.25 Interestingly, Meirhaeghe et al16 reported that in
sedentary men, those carrying the Gln27Gln genotype had
higher body weight, BMI and WHR, as compared with Glu27
carriers. In contrast, the risk of becoming obese was not
increased in men reporting regular physical activity. There-
fore, based on these studies16,25 we could conclude that
obese individuals with the ADRB2 Gln27Gln genotype may
benefit from physical activity to reduce their weight.16 This
is in line with our findings since lipolysis and fat oxidation
during exercise were higher in our Gln27Gln group as
compared to the Glu27Glu group, so again, the Gln27Gln
genotype (lacking the Glu27 allele) seems to benefit more
from exercise. Studies with identical twins would have pro-
vided clearer evidence,39 but neither twins, nor siblings were
found in our obese population, so homozygous Glu27Glu
obese women were matched with other group of homozy-
gous Gln27Gln women. This design has also been reported
in similar studies.27
Longer times of mild exercise would have provided a
greater lipolysis,40 but 1 h was a sufficient stimulus, given
that glycerol and plasma FFA release into bloodstream
increased significantly with the onset of exercise. Moreover,
a decrease in plasma insulin and an increase in sympatho-
adrenal activity are considered the major determinants ofT
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Figure 2 Respiratory quotient (A) during the whole study and fat
oxidation (mg=min) (B) at baseline, exercise and recovery.
###P<0.001 (by RMFA for time); *P<0.05 (by unpaired Student’s
t-test, Glu27Glu vs Gln27Gln).
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fat cell lipolysis in exercise,29 which was reflected in our
study. Recently, it has been reported that homozygous
subjects for the Arg allele in amino acid 16 of the ADRB2
had lower levels of FFA when they are physically active.23
Given that homozigosity of the Arg16 allele most commonly
occurs with the genotype Gln27Gln,11,19 we would expect
lower FFA in the Gln27Gln group with exercise in our study.
This could explain the profile followed, although no
differences were detected between groups.
The higher RQ in the Glu27Glu group suggests that the
blend of oxidized fuels during the recovery is poorer in lipid
content than it is in the Gln27Gln group. This was con-
firmed with fat oxidation calculations, which did not differ
either at baseline and exercise, but showed a diminished fat
oxidation in the Glu27Glu group at recovery time.
Ketogenesis, a marker of fat oxidation, is a key pathway in
providing energy to fuel gluconeogenesis.41 The fact that
plasma hydroxybutyrate was lower in the Glu27Glu group
both at basal and during light exercise, suggests that fat
oxidation is diminished in these subjects. In this context,
circulating lactate remained significantly higher in the
Glu27Glu group along the study, which could reflect
the search of alternative energy sources different from fat.
In accordance with other studies that found higher trigly-
ceridaemia in subjects bearing the Glu allele,13,19,42,43 plasma
triglycerides (TG) remained higher in our Glu27Glu group
than in the Gln27Gln group throughout the study. On the
other hand, the only measured hormone that significantly
differed between groups was insulin, which was higher in the
Glu27Glu group. This is in line with other studies that
reported that the frequency of the Glu27 allele is higher in
patients with non-insulin-dependent diabetes mellitus than
in non-diabetic subjects.13 Similarly, Large et al found that
Glu27Glu women had higher fasting plasma insulin level
than the other genotypes.11 It is believed that resistance to
insulin-stimulated glucose uptake with compensatory hyper-
insulinemia is the primary culprit in the metabolic
syndrome,44 which is accompanied by high TG and low
HDL cholesterol.45 Moreover, high levels of both serum
insulin and TG appear to be among the three metabolic
variables that closest correlated with obesity in a recent study
based on 1010 subjects.46 In our study, the higher insulin
and TG levels in the Glu27Glu group along the study could
lead to future insulin resistance and DM linked to this
polymorphism, as previously reported.13 Given that
Trp64Arg polymorphism in the b3-adrenoceptor has been
linked to an early onset of NIDDM47 and insulin resistance,48
we wondered if the increased insulin in the variant
Glu27Glu group could be due to a simultaneous presence
of the Trp64Arg polymorphism. This possibility was
excluded since data from a previous investigation on the
same subjects49 revealed that there were only two hetero-
zygous Trp64Arg, but in the Gln27Gln group.
A number of recent reviews,50,51 have shown that the
lipolytic action of the catecholamines is blunted in vivo in
obese subjects. Also, a decreased ADRB2 function in the
subcutaneous adipocytes of obese adults has been reported.52
Although no statistical differences were found between
groups in plasma catecholamines throughout our study,
noradrenaline tended to be higher in the variant group
(P¼0.090), suggesting that the exercise released norepine-
phrine induced lipolysis could be blunted in the poly-
morphic Glu27Glu group.
These results cannot be attributable solely to a defect in
the ADRB2 activation in the Glu27Glu group, since the
reesterification of FFA and glycerol into TG, as well as
the mechanisms between activation of the adrenoceptors
and the breaking down of TG into FFA and glycerol could
also be involved. The possibility, that our results are due to a
cluster of polymorphisms that have yet to be studied, cannot
be excluded. In this line, analysis of homozygous genotypes
revealed that the Cys19Cys genotype in the 50 leader cistron
most commonly occurs with Gln27Gln.8 Since receptor
expression was approximately two-fold higher in those bear-
ing the Cys polymorphism, our results could also be attribu-
table to this major expected ADRB2 expression in the
Gln27Gln.
In conclusion, the present data suggest that in female
obese subjects, both lipolysis and fat oxidation promoted by
an acute submaximal exercise intervention appear blunted
in the polymorphic Glu27Glu group vs the Gln27Gln group.
These results provide useful information on the role of the
Gln27Glu polymorphism in the etiology of human obesity
and on its subsequent therapy.
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